Uwoyela Kakhukhunathi

-Delile

• Kungenzeka kusebenze ...
• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

Uwoyela kakhukhunathi uvela kumantongomane (izithelo) zesundu sikakhukhunathi. Amafutha wamantongomane asetshenziselwa ukwenza umuthi. Eminye imikhiqizo kawoyela kakhukhunathi ibizwa ngamafutha "kakhulukazi" kakhukhunathi. Ngokungafani namafutha omnqumo, ayikho indinganiso esezingeni lomkhakha yencazelo kawoyela "kakhulukazi" kakhukhunathi. Leli gama selisho ukuthi uwoyela ngokuvamile awenziwanga. Isibonelo, uwoyela kakhukhunathi oseyintombi ngokuvamile awukakhanjiswa, awususwanga amakhowa, noma awucwengiswanga.

Eminye imikhiqizo kawoyela kakhukhunathi ithi "icindezelwe abandayo" uwoyela kakhukhunathi. Lokhu ngokuvamile kusho ukuthi kusetshenziswa indlela yokulungisa uwoyela, kepha ngaphandle kokusebenzisa noma yimuphi umthombo wokushisa ongaphandle. Ingcindezi ephezulu edingekayo ukucindezela uwoyela ikhiqiza ukushisa okuthile ngokwemvelo, kepha izinga lokushisa lilawulwa ukuze amazinga okushisa angeqi ku-120 degrees Fahrenheit.

Abantu basebenzisa uwoyela kakhukhunathi nge-eczema (atopic dermatitis). Ibuye isetshenziselwe isikhumba esibi, esilumayo (i-psoriasis), ukukhuluphala, nezinye izimo, kepha abukho ubufakazi obuhle besayensi bokuxhasa lokhu kusetshenziswa.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze NGAMAFUTHA KAKHONONONI zimi kanje:

Kungenzeka kusebenze ...

• I-eczema (i-atopic dermatitis). Ukufaka uwoyela kakhukhunathi esikhunjeni kunganciphisa ubunzima be-eczema ezinganeni cishe ngama-30% ngaphezulu kukawoyela wamaminerali.

Ubufakazi obanele bokukala ukusebenza kwe ...

• Ukusebenza kwezemidlalo. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha uwoyela kakhukhunathi nge-caffeine kubonakala kungabasizi abantu ukugijima ngokushesha.
• Umdlavuza webele. Ucwaningo lokuqala lukhombisa ukuthi ukuthatha uwoyela kakhukhunathi oyintombi ngomlomo ngesikhathi se-chemotherapy kungahle kuthuthukise izinga lempilo kwabanye besifazane abanomdlavuza webele osezingeni eliphezulu.
• Isifo senhliziyo. Abantu abadla ukhukhunathi noma abasebenzisa uwoyela kakhukhunathi ukupheka ababonakali benengozi ephansi yokuhlaselwa yisifo senhliziyo. Futhi azibonakali zinengcuphe ephansi yobuhlungu besifuba. Ukusebenzisa uwoyela kakhukhunathi ukupheka futhi kwehlisi i-cholesterol noma kuthuthukise ukugeleza kwegazi kubantu abanesifo senhliziyo.
• Uqwembe lwamazinyo. Ucwaningo lwakuqala lukhombisa ukuthi ukudonsa uwoyela kakhukhunathi ngamazinyo kungavimbela ukwakheka kocwecwe. Kodwa akubonakali kuzuzisa zonke izindawo zamazinyo.
• Uhudo. Ucwaningo olulodwa ezinganeni lwathola ukuthi ukufaka uwoyela kakhukhunathi ekudleni kunganciphisa ubude besifo sohudo. Kepha olunye ucwaningo luthole ukuthi alusebenzi kangako njengokudla okususelwa enkomeni. Umphumela kawoyela kakhukhunathi uwodwa awucaci.
• Isikhumba esomile. Ucwaningo lwakuqala lukhombisa ukuthi ukufaka uwoyela kakhukhunathi esikhunjeni kabili ngosuku kungathuthukisa umswakama wesikhumba kubantu abanesikhumba esomile.
• Ukushona kwengane engakazalwa noma engakazalwa ngaphambi kwesikhathi. Ucwaningo lwakuqala lukhombisa ukuthi ukufaka uwoyela kakhukhunathi esikhunjeni sengane engakafiki isikhathi akwehlisi ingozi yokufa. Kepha kunganciphisa ubungozi bokutheleleka esibhedlela.
• Izintwala. Ukuthuthukisa ucwaningo kukhombisa ukuthi ukusebenzisa isifutho esiqukethe uwoyela kakhukhunathi, uwoyela we-anise, namafutha e-ylang ylang kungasiza ekwelapheni izintwala zekhanda ezinganeni.Kubonakala sengathi isebenza mayelana nesifutho esiqukethe izinambuzane zamakhemikhali. Kodwa akucaci ukuthi le nzuzo ingenxa kawoyela kakhukhunathi, ezinye izithako, noma inhlanganisela.
• Izinsana ezizalwe zinesisindo esingaphansi kwama-2500 amagremu (amakhilogremu ama-5, ama-ounces ayi-8). Abanye abantu banikeza uwoyela kakhukhunathi ezinganeni ezincane ezincela ibele ukuze zizisize zikhuluphale. Kodwa akubonakali kusiza izinsana ezizalwe zinesisindo esingaphansi kuka-1500 amagremu.
• I-Multiple sclerosis (MS). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha uwoyela kakhukhunathi ngekhemikhali elivela kwitiye eluhlaza ebizwa nge-EGCG kungasiza ukunciphisa imizwa yokukhathazeka nokwenza ngcono ukusebenza kwabantu abane-MS.
• Ukukhuluphala ngokweqile. Olunye ucwaningo lukhombisa ukuthi ukuthatha uwoyela kakhukhunathi ngomlomo amasonto ayi-8 kanye nokudla nokuvivinya umzimba kuholela ekwehleni kwesisindo okuphawuleka kwabesifazane abakhuluphele kakhulu uma kuqhathaniswa nokuthatha uwoyela wesoya noma uwoyela we-chia. Olunye ucwaningo lwakuqala lukhombisa ukuthi ukuthatha uwoyela kakhukhunathi isonto elilodwa kunganciphisa usayizi wokhalo uma kuqhathaniswa namafutha wesoya kwabesifazane abanamafutha amaningi azungeze isisu nesisu. Kepha obunye ubufakazi bukhombisa ukuthi ukuthatha uwoyela kakhukhunathi amasonto ama-4 kunciphisa usayizi wokhalo uma kuqhathaniswa nesisekelo emadodeni akhuluphele kuphela kepha hhayi abesifazane.
• Ukukhula nentuthuko ezinganeni ezingaphambi kwesikhathi. Izinsana ezingakazalwa zinesikhumba esingavuthiwe. Lokhu kungandisa amathuba abo okuthola ukutheleleka. Olunye ucwaningo lukhombisa ukuthi ukufaka uwoyela kakhukhunathi esikhunjeni sezinsana ezizalwe ngaphambi kwesikhathi kuthuthukisa amandla esikhumba sabo. Kodwa akubonakali kunciphisa amathuba abo okuthola ukutheleleka. Olunye ucwaningo lukhombisa ukuthi ukubhucunga izinsana ezisanda kuzalwa ngamafutha kakhukhunathi kungathuthukisa ukukhula kwesisindo nokukhula.
• Isikhumba, isikhumba esilumayo (psoriasis). Ukufaka uwoyela kakhukhunathi esikhunjeni ngaphambi kokwelapha okulula kwe-psoriasis akubonakali kuthuthukisa imiphumela yokwelashwa okulula.
• Isifo i-Alzheimer.
• Isifo sokukhathala okungamahlalakhona (CFS).
• Uhlobo lwesifo samathumbu esivuthayo (isifo seCrohn).
• Isifo sikashukela.
• Ukuphazamiseka kwesikhathi eside kwamathumbu amakhulu okubangela ubuhlungu besisu (i-irritable bowel syndrome noma i-IBS).
• Izimo ze-thyroid.
• Ezinye izimo.

Kudingeka ubufakazi obuningi ukukala uwoyela kakhukhunathi ngalokhu kusetshenziswa. Uwoyela kakhukhunathi uqukethe uhlobo oluthile lwamafutha aziwa ngokuthi "i-medium chain triglycerides." Amanye ala mafutha asebenza ngokuhlukile kunezinye izinhlobo zamafutha agcwele emzimbeni. Lapho isetshenziswa esikhunjeni, uwoyela kakhukhunathi unomphumela wokuthambisa.

Lapho ithathwa ngomlomo: Uwoyela kakhukhunathi uyi CISHE UVIKILE lapho ithathwa ngomlomo ngamanani okudla. Kepha uwoyela kakhukhunathi uqukethe uhlobo lwamafutha olungakhuphula amazinga e-cholesterol. Ngakho-ke abantu kufanele bagweme ukudla uwoyela kakhukhunathi ngokweqile. Uwoyela kakhukhunathi unjalo OKUNGENZEKA UKUPHEPHA lapho isetshenziswa njengomuthi isikhathi esifushane. Ukuthatha uwoyela kakhukhunathi ngemithamo ye-10 mL kabili noma kathathu nsuku zonke kuze kube amasonto ayi-12 kubonakala kuphephile.

Lapho isetshenziswa esikhunjeni: Uwoyela kakhukhunathi uyi CISHE UVIKILE lapho isetshenziswa esikhumbeni.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Alukho ulwazi olwanele olunokwethenjelwa ukwazi ukuthi uwoyela kakhukhunathi uphephile yini ukusetshenziswa lapho ukhulelwe noma uncelisa ibele. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Izingane: Uwoyela kakhukhunathi uyi OKUNGENZEKA UKUPHEPHA lapho isetshenziswa esikhumbeni cishe inyanga eyodwa. Alukho ulwazi olwanele oluthembekile lokwazi ukuthi ngabe uwoyela kakhukhunathi uphephile yini ezinganeni lapho zithathwa ngomlomo njengomuthi.

I-cholesterol ephezulu: Uwoyela kakhukhunathi uqukethe uhlobo lwamafutha olungakhuphula amazinga e-cholesterol. Ukudla njalo ukudla okuqukethe uwoyela kakhukhunathi kungakhuphula amazinga we-cholesterol "ephansi" ye-lipoprotein cholesterol. Lokhu kungaba yinkinga kubantu asebevele bene-cholesterol ephezulu.

Akwaziwa ukuthi lo mkhiqizo uyaxhumana yini nemithi ethile.

Ngaphambi kokuthatha lo mkhiqizo, khuluma nodokotela wakho wezempilo uma usebenzisa noma imiphi imithi.

I-psyllium emhlophe

I-Psyllium inciphisa ukumuncwa kwamafutha emafutheni kakhukhunathi.

Akukho ukuxhumana okwaziwayo nokudla.

Umthamo olandelayo ufundwe ocwaningweni lwesayensi:

IZINGANE

Kusetshenziswe esikhunjeni:

• Nge-eczema (atopic dermatitis)I-10 mL kawoyela kakhukhunathi oyintombi usetshenzisiwe ezindaweni eziningi zomzimba ngemithamo emibili ehlukanisiwe nsuku zonke amasonto ayi-8.

Aceite de Coco, Acide Gras de Noix de Coco, Coconut Fatty Acid, Coconut Palm, Coco Palm, Coconut, Cocos nucifera, Cocotier, Cold Pressed Coconut Oil, Fermented Coconut Oil, Huile de Coco, Huile de Noix de Coco, Huile de Noix de Coco Pressée à Froid, Huile Vierge de Noix de Coco, Narikela, Noix de Coco, Palmier, Virgin Coconut Oil.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. UStrunk T, uGummer JPA, u-Abraham R, et al. Amafutha Kakhukhunathi Aphezulu Anikela Kumazinga Ase-Monolaurin Ezinsaneni Ezisanda Kuzalwa. I-Neonatology. 2019; 116: 299-301. Buka okungaqondakali.
2. USezgin Y, uMemis Ozgul B, i-Alptekin NO. Ukusebenza kokwelapha ngokudonsa uwoyela ngamafutha kakhukhunathi ekukhuleni kwamapuleti we-supragingival wezinsuku ezine: Isivivinyo somtholampilo esingahleliwe. Qedelela iTher Med. 2019; 47: 102193. Buka okungaqondakali.
3. UNeelakantan N, Seah JYH, i-van Dam RM. Umphumela wokusetshenziswa kukawoyela kakhukhunathi ezintweni ezinobungozi benhliziyo: Ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kokuhlolwa kwemitholampilo. Ukujikeleza. 2020; 141: 803-814. Buka okungaqondakali.
4. UPlatero JL, uCuerda-Ballester M, Ibáñez V, et al. Umthelela kawoyela kakhukhunathi kanye ne-epigallocatechin gallate emazingeni e-IL-6, ukukhathazeka nokukhubazeka ezigulini eziningi ze-sclerosis. Izakhamzimba. 2020; 12. pii: E305. Buka okungaqondakali.
5. U-Arun S, uKumar M, uPaul T, et al. Isivivinyo esilawulwa ngokungahleliwe esinelebuli yokuqhathanisa ukuzuza kwesisindo sezinsana ezinesisindo sokuzalwa esiphansi kakhulu noma ngaphandle kokungezelwa kukakhukhunathi kubisi lwebele. J Trop Ingane yezingane. 2019; 65: 63-70. Buka okungaqondakali.
6. UBorba GL, uBatista JSF, uNovais LMQ, et al. Ukudla okune-caffeine kanye nowoyela kakhukhunathi, okuhlukanisiwe noma okuhlanganisiwe, akuzithuthukisi izikhathi zokugijima zabagijimi bokuzijabulisa: Ucwaningo olwenziwe ngokungahleliwe, olulawulwa yi-placebo nolwe-crossover. Izakhamzimba. 2019; 11. i-pii: E1661. Buka okungaqondakali.
7. UKonar MC, Islam K, Roy A, Ghosh T. Umphumela wesicelo se-virgin coconut oil esikhunjeni sezinsana ezisanda kuzalwa: Isivivinyo esilawulwa ngokungahleliwe. UJ Trop Ingane yezingane. 2019. pii: fmz041. Buka okungaqondakali.
8. I-Famurewa AC, Ekeleme-Egedigwe CA, Nwali SC, Agbo NN, Obi JN, Ezechukwu GC. Ukwengezwa kokudla ngamafutha kakhukhunathi ayintombi kuthuthukisa iphrofayili ye-lipid nesimo se-hepatic antioxidant futhi kunezinzuzo ezingaba khona kuma-indices engcuphe yenhliziyo kumagundane ajwayelekile. J Ukudla Suppl. I-2018; 15: 330-342. Buka okungaqondakali.
9. UValente FX, uCândido FG, uLopes LL, et al. Imiphumela yokusetshenziswa kukawoyela kakhukhunathi kumandla we-metabolism, izimpawu zokubeka engcupheni ye-cardiometabolic, nezimpendulo zokuphefumula kwabesifazane abanamafutha omzimba amaningi. Eur J Umsoco. 2018; 57: 1627-1637. Buka okungaqondakali.
10. UNarayanankutty A, uPalliyil DM, uKuruvilla K, uRaghavamenon AC. Amafutha kakhukhunathi eVirgin abuyisela emuva i-hepatic steatosis ngokubuyisela i-redox homeostasis kanye ne-lipid metabolism kumagundane wesilisa eWistar. J Sci Ukudla Agric. 2018; 98: 1757-1764. Buka okungaqondakali.
11. Khaw KT, Sharp SJ, Finikarides L, et al. Isivivinyo esingahleliwe samafutha kakhukhunathi, uwoyela womnqumo noma ibhotela kuma-lipids egazi nezinye izinto ezinobungozi benhliziyo kumadoda nabesifazane abaphilile. BMJ Vula. 2018; 8: e020167. Buka okungaqondakali.
12. U-Oliveira-de-Lira L, iSantos EMC, de Souza RF, et al. Imiphumela encike ekwengezelweni kawoyela wemifino enezingqimba ezahlukahlukene zama-asidi kuma-anthropometric kanye ne-biochemical parameter kwabesifazane abakhuluphele. Izakhamzimba. 2018; 10. pii: E932. Buka okungaqondakali.
13. UKinsella R, uMaher T, uClegg ME. Uwoyela kakhukhunathi unezinto zokusuthisa okuncane kunamafutha we-chain triglyceride aphakathi. UPhysiol Behav. 2017 Okthoba 1; 179: 422-26. Buka okungaqondakali.
14. UVijayakumar M, uVasudevan DM, uSundaram KR, et al. Ucwaningo olwenziwe ngokungahleliwe lwamafutha kakhukhunathi uma kuqhathaniswa namafutha e-sunflower ezintweni ezinobungozi benhliziyo ezigulini ezinesifo senhliziyo esizinzile. Inhliziyo yaseNdiya J. 2016 Jul-Aug; 68: 498-506. Buka okungaqondakali.
15. UStrunk T, uPupala S, uHibbert J, uDoherty D, uPatole S. Amafutha kakhukhunathi aphezulu ezinganeni ezisandulela ukuzalwa: isilingo esilawulwa ngokungahleliwe. I-Neonatology. 2017 Dec 1; 113: 146-151. Buka okungaqondakali.
16. UMichavila Gomez A, Amat Bou M, Gonzalez Cortés MV, Segura Navas L, Moreno Palanques MA, Bartolomé B. Coconut anaphylaxis: Umbiko wecala nokubuyekezwa. I-Allergol Immunopathol (Madr). 2015; 43: 219-20. Buka okungaqondakali.
17. U-Anagnostou K. Ukwelashwa Kokukhukhumeza Kwekhukhunathi Kubuye Kubhekwe. Izingane (Basel). 2017; 4. pii: E85. Buka okungaqondakali.
18. Amasaka FM, Lichtenstein AH, Wu JHY, et al .; Inhlangano Yezinhliziyo ZaseMelika. Amafutha Okudla kanye Nezifo Zenhliziyo: Iseluleko SikaMongameli Esivela Ku-American Heart Association. Ukusakazwa kuka-2017; 136: e1-e23. Buka okungaqondakali.
19. I-Eyres L, i-Eyres MF, i-Chisholm A, i-Brown RC. Ukusetshenziswa kukawoyela kakhukhunathi nezinto ezinobungozi benhliziyo kubantu. Umsoco Rev 2016; 74: 267-80. Buka okungaqondakali.
20. IVoon PT, Ng TK, Lee VK, Nesaretnam K. Ukudla okuphezulu nge-palmitic acid (16: 0), i-lauric ne-myristic acid (12: 0 + 14: 0), noma i-oleic acid (18: 1) ayiguquli i-postprandial noma ukuzila ukudla kwe-plasma homocysteine ​​nezimpawu zokuvuvukala kubantu abadala baseMalaysia abaphilile. Ngingu-J J Nutriti 2011; 94: 1451-7. Buka okungaqondakali.
21. UCox C, uMann J, uSutherland W, et al Imiphumela yamafutha kakhukhunathi, ibhotela, kanye namafutha okugcoba kuma-lipids nama-lipoprotein kubantu abanamazinga aphezulu we-cholesterol. UJ Lipid Res 1995; 36: 1787-95. Buka okungaqondakali.
22. Inhlangano Yezokudla Nezolimo yeNhlangano Yezizwe. ISIQEPHU 2. Amazinga we-Codex wamafutha namafutha avela kwimithombo yemifino. Kutholakala ku: http://www.fao.org/docrep/004/y2774e/y2774e04.htm#TopOfPage. Kufinyelelwe ngo-Okthoba 26, 2015.
23. UMarina AM, uChe Man YB, u-Amin I. Uwoyela kakhukhunathi waseVirgin: uwoyela wokudla osebenzayo. Amathrendi Ukudla Sci Technol. U-2009; 20: 481-487.
24. I-Salam RA, iDarmstadt GL, iBhutta ZA. Umphumela wokwelashwa okukhiphayo emiphumeleni yomtholampilo kuma-preterm neonates ePakistan: isilingo esilawulwa ngokungahleliwe. I-Arch Dis Ingane Ingane Engakazalwa Ed. 2015 Meyi; 100: F210-5. Buka okungaqondakali.
25. Umthetho KS, Azman N, Omar EA, Musa MY, Yusoff NM, Sulaiman SA, Hussain NH. Imiphumela yamafutha kakhukhunathi ayizintombi (VCO) njengokungezelela kwikhwalithi yempilo (QOL) phakathi kweziguli ezinomdlavuza webele. I-Lipids Health Dis. 2014 Aug 27; 13: 139. Buka okungaqondakali.
26. U-Evangelista MT, u-Abad-Casintahan F, uLopez-Villafuerte L. Umphumela wamafutha kakhukhunathi ayizintombi ku-SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate atopic dermatitis: a randomized, blind-blind, clinical trial. I-Int J Dermatol. 2014 uJan; 53: 100-8. Buka okungaqondakali.
27. UBhan MK, Arora NK, Khoshoo V, et al. Ukuqhathaniswa kwefomula engena-cereal-free okususelwa kubisi kanye nobisi lwenkomo ezinganeni nasezinganeni ezine-gastroenteritis ebukhali. J Pediatr Gastroenterol Nutriti 1988; 7: 208-13. Buka okungaqondakali.
28. URomer H, uGuerra M, uPina JM, et al. Ukuvuselelwa kwezingane eziphelelwe ngamanzi ezinesifo sohudo esibuhlungu: ukuqhathanisa ubisi lwenkomo nefomula esekelwe enkukhu. UJ Pediatr Gastroenterol Nutriti 1991; 13: 46-51. Buka okungaqondakali.
29. ULiau KM, uLee YY, uKen CK, uRasool AH. Ucwaningo lomshayeli ovulekile olunelebula lokuhlola ukusebenza nokuphepha kukawoyela kakhukhunathi oyintombi ekwehliseni ukungathandeki kwe-visceral. I-ISRN Pharmacol 2011; 2011: 949686. Buka okungaqondakali.
30. UBurnett CL, uBergfeld WF, uBelsito DV, et al. Umbiko wokugcina wokuhlolwa kokuphepha kukawoyela weCocos nucifera (kakhukhunathi) nezithako ezihlobene nazo. I-Int J Toxicol 2011; 30 (3 Suppl): 5S-16S. Buka okungaqondakali.
31. UFeranil AB, uDuazo PL, uKuzawa CW, u-Adair LS. Uwoyela kakhukhunathi uhlotshaniswa nephrofayili ezuzisayo ye-lipid kwabesifazane bangaphambi kokuya esikhathini ePhilippines. I-Asia Pac J Clin Nutriti 2011; 20: 190-5. Buka okungaqondakali.
32. UZakaria ZA, uRofiee MS, uSomchit MN, et al. Umsebenzi we-hepatoprotective wamafutha kakhukhunathi asetshenzisiwe futhi omisiwe. I-Evid Based Complement Alternat Med 2011; 2011: 142739. Buka okungaqondakali.
33. I-Assunção ML, iFerreira HS, i-dos Santos AF, et al. Imiphumela yamafutha kakhukhunathi wokudla kumaphrofayli we-biochemical kanye ne-anthropometric yabesifazane abethula ukukhuluphala kwesisu. I-Lipids 2009; 44: 593-601. Buka okungaqondakali.
34. USankaranarayanan K, uMondkar JA, uChahan MM, et al. Ukuhlikihla u-oyela kuma-neonates: isifundo esivulekile esilawulwa ngokungahleliwe sikakhukhunathi kuqhathaniswa namafutha amaminerali I-Indian Pediatr 2005; 42: 877-84. Buka okungaqondakali.
35. I-Agero AL, iVerallo-Rowell VM. Isilingo esilawulwa ngokungahleliwe esilawulwa ngokuqhathanisa uwoyela owengeziwe we-virgin coconut namafutha amaminerali njenge-moisturizer ye-xerosis emnene naphakathi. Isikhumba 2004; 15: 109-16. Buka okungaqondakali.
36. UCox C, uSutherland W, uMann J, et al. Imiphumela yokudla kawoyela kakhukhunathi, ibhotela kanye ne-safflower oyela kuma-lipids e-plasma, ama-lipoproteins namazinga e-lathosterol. I-Eur J Clin Nutr 1998; 52: 650-4. Buka okungaqondakali.
37. Amafry JH, amafries MW. Ukhukhunathi: ukubuyekezwa kokusetshenziswa kwayo njengoba kuhlobene nomuntu ongezwani nezinto ezithile. Ann Ukungezwani komzimba 1983; 51: 472-81. Buka okungaqondakali.
38. I-Kumar PD. Indima kawoyela kakhukhunathi nowokhukhunathi ku-coronary heart disease eKerala, eningizimu yeNdiya. Trop Doct 1997; 27: 215-7. Buka okungaqondakali.
39. UGarcia-Fuentes E, uGil-Villarino A, uZafra MF, uGarcia-Peregrin E.I-Dipyridamole ivimbela i-hypercholesterolemia eyenziwe ngoyela lukakhukhunathi. Ucwaningo olwenziwe nge-lipid plasma kanye ne-lipoprotein composition. I-Int J Biochem Cell Biol 2002; 34: 269-78. Buka okungaqondakali.
40. UGanji V, uKies CV. I-Psyllium husk fiber supplementation kuma-soybean kanye nohlobo lwamafutha kakhukhunathi kubantu: umphumela ekugayekeni kwamafutha nasekukhipheni i-faecal fatty acid. I-Eur J Clin Nutriti 1994; 48: 595-7. Buka okungaqondakali.
41. UFrancois CA, uConnor SL, uWander RC, uConnor WE. Imiphumela emibi yama-acid okunamafutha ekudleni kuma-acid okunamafutha obisi lomuntu. Ngingu-J J Nutriti 1998; 67: 301-8. Buka okungaqondakali.
42. UMumcuoglu KY, Miller J, Zamir C, et al. Ukusebenza kwe-in vivo pediculicidal kwekhambi lemvelo. I-Isr Med Assoc J 2002; 4: 790-3. Buka okungaqondakali.
43. UMuller H, uLindman AS, uBlomfeldt A, et al. Ukudla okunothile ngamafutha kakhukhunathi kunciphisa ukwehluka kwe-diurnal postprandial ekusakazeni izicubu zeplasminogen activator antigen kanye ne-lipoprotein yokuzila (a) uma kuqhathaniswa nokudla okunothe ngamafutha angagcwali kwabesifazane. J Okunempilo 2003; 133: 3422-7. Buka okungaqondakali.
44. U-Alexaki A, Wilson TA, Atallah MT, et al. AmaHamsters ondle ukudla okunamafutha agcwele akhulise ukuqongelelwa kwe-cholesterol nokukhiqizwa kwe-cytokine ku-aortic arch uma kuqhathaniswa nama-hamster aphethwe yi-cholesterol anezingqinamba ze-cholesterol ezingekho ze-HDL eziphakanyisiwe. UJ Nutriti 2004; 134: 410-5. Buka okungaqondakali.
45. UReiser R, uProbstfield JL, uSilvers A, et al. Impendulo ye-Plasma lipid ne-lipoprotein yabantu kumafutha enkomo, uwoyela kakhukhunathi kanye namafutha we-safflower. Ngingu-J J Nutriti 1985; 42: 190-7. Buka okungaqondakali.
46. UTella R, uGaig P, uLombardero M, et al. Icala lokungezwani komzimba kakhukhunathi. Ukungezwani komzimba 2003; 58: 825-6.
47. ITeuber SS, uPeterson WR. Ukusabela okwehlukile kokungezwani komzimba kukakhukhunathi (iCocos nucifera) ezifundweni ezi-2 ezine-hypersensitivity to nut tree kanye nokukhonjiswa kokuphambuka kokusebenza kabusha kwamaprotheni okugcina imbewu afana ne-legumin: ukhukhunathi omusha kanye nokungezwani kokudla kwamantongomane. J Ukungezwani komzimba ne-Immunol 1999; 103: 1180-5. Buka okungaqondakali.
48. UMendis S, Samarajeewa U, Thattil RO. Amafutha kakhukhunathi kanye ne-serum lipoproteins: imiphumela yokushintshwa ngokwengxenye ngamafutha angagcwele. UBr J Nutr 2001; 85: 583-9. Buka okungaqondakali.
49. ULaureles LR, uRodriguez FM, uReano CE, et al. Ukuhlukahluka kwe-fatty acid nokwakheka kwe-triacylglycerol kwamafutha kakhukhunathi (Cocos nucifera L.) nzalo kanye nabazali babo. J Agric Ukudla Chem 2002; 50: 1581-6. Buka okungaqondakali.
50. UGeorge SA, uBilsland DJ, uWainwright NJ, uFerguson J. Ukwehluleka kukawoyela kakhukhunathi ukusheshisa imvume ye-psoriasis ku-band-UVB phototherapy noma i-photochemotherapy emincane. UBr J Dermatol 1993; 128: 301-5. Buka okungaqondakali.
51. IBach AC, iBabayan VK. Medium-chain triglycerides: isibuyekezo. Ngingu-J J Nutriti 1982; 36: 950-62. Buka okungaqondakali.
52. I-Ruppin DC, iMiddleton WR. Ukusetshenziswa kwemitholampilo kwe-triglycerides yamaketanga aphakathi. Izidakamizwa 1980; 20: 216-24.

Kugcine ukubuyekezwa - 09/30/2020